These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8807659)
21. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1. Kurata N; Nishimura Y; Iwase M; Fischer NE; Tang BK; Inaba T; Yasuhara H Xenobiotica; 1998 Nov; 28(11):1041-7. PubMed ID: 9879636 [TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737 [TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. Neafsey P; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):362-88. PubMed ID: 20183527 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene]. Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810 [TBL] [Abstract][Full Text] [Related]
25. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism. Lee AM; Joshi M; Yue J; Tyndale RF Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344 [TBL] [Abstract][Full Text] [Related]
26. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats. Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723 [TBL] [Abstract][Full Text] [Related]
27. Phenotyping of cytochrome P450 2E1 in vitro and in vivo. Ernstgård L; Johanson G; Karlsson AS; Warholm M Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020 [TBL] [Abstract][Full Text] [Related]
28. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5. Wiercinska P; Squires EJ Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110 [TBL] [Abstract][Full Text] [Related]
29. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304 [TBL] [Abstract][Full Text] [Related]
30. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018 [TBL] [Abstract][Full Text] [Related]
31. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Liu R; Yin LH; Pu YP Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774 [TBL] [Abstract][Full Text] [Related]
32. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991 [TBL] [Abstract][Full Text] [Related]
33. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Gebhardt AC; Lucas D; Ménez JF; Seitz HK Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319 [TBL] [Abstract][Full Text] [Related]
34. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. McCarver DG; Byun R; Hines RN; Hichme M; Wegenek W Toxicol Appl Pharmacol; 1998 Sep; 152(1):276-81. PubMed ID: 9772223 [TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988 [TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Hu Y; Oscarson M; Johansson I; Yue QY; Dahl ML; Tabone M; Arincò S; Albano E; Ingelman-Sundberg M Mol Pharmacol; 1997 Mar; 51(3):370-6. PubMed ID: 9058590 [TBL] [Abstract][Full Text] [Related]
37. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Kim RB; O'Shea D; Wilkinson GR Pharmacogenetics; 1994 Jun; 4(3):162-5. PubMed ID: 7920697 [No Abstract] [Full Text] [Related]
38. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18. Minoletti C; Dijols S; Dansette PM; Mansuy D Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023 [TBL] [Abstract][Full Text] [Related]
40. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Carriere V; Goasduff T; Ratanasavanh D; Morel F; Gautier JC; Guillouzo A; Beaune P; Berthou F Chem Res Toxicol; 1993; 6(6):852-7. PubMed ID: 7509644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]